Literature DB >> 27308631

MDM2/MDMX: Master negative regulators for p53 and RB.

Linshan Hu1, Haibo Zhang1, Johann Bergholz1, Shengnan Sun1, Zhi-Xiong Jim Xiao1.   

Abstract

MDM2 (mouse double minute 2 homolog) and MDMX (double minute X human homolog, also known as MDM4) are critical negative regulators of tumor protein p53. Our recent work shows that MDMX binds to and promotes degradation of retinoblastoma protein (RB) in an MDM2-dependent manner. In a xenograft tumor growth mouse model, silencing of MDMX results in inhibition of p53-deficient tumor growth, which can be effectively reversed by concomitant RB silencing. Thus, MDMX exerts its oncogenic activity via suppression of RB.

Entities:  

Keywords:  MDM2; MDMX; RB; p53

Year:  2016        PMID: 27308631      PMCID: PMC4905407          DOI: 10.1080/23723556.2015.1106635

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN: 2372-3556


  10 in total

Review 1.  Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4.

Authors:  J-C Marine; S Francoz; M Maetens; G Wahl; F Toledo; G Lozano
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

2.  MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein.

Authors:  Patima Sdek; Haoqiang Ying; Donny L F Chang; Wei Qiu; Hongwu Zheng; Robert Touitou; Martin J Allday; Zhi-Xiong Jim Xiao
Journal:  Mol Cell       Date:  2005-12-09       Impact factor: 17.970

3.  MDMX exerts its oncogenic activity via suppression of retinoblastoma protein.

Authors:  H Zhang; L Hu; W Qiu; T Deng; Y Zhang; J Bergholz; Z-X Xiao
Journal:  Oncogene       Date:  2015-02-23       Impact factor: 9.867

4.  Inactivation of the p53 pathway in retinoblastoma.

Authors:  Nikia A Laurie; Stacy L Donovan; Chie-Schin Shih; Jiakun Zhang; Nicholas Mills; Christine Fuller; Amina Teunisse; Suzanne Lam; Yolande Ramos; Adithi Mohan; Dianna Johnson; Matthew Wilson; Carlos Rodriguez-Galindo; Micaela Quarto; Sarah Francoz; Susan M Mendrysa; R Kiplin Guy; Jean-Christophe Marine; Aart G Jochemsen; Michael A Dyer
Journal:  Nature       Date:  2006-11-02       Impact factor: 49.962

5.  The central acidic domain of MDM2 is critical in inhibition of retinoblastoma-mediated suppression of E2F and cell growth.

Authors:  Patima Sdek; Haoqiang Ying; Hongwu Zheng; Alexander Margulis; Xiaoren Tang; Kui Tian; Zhi-Xiong Jim Xiao
Journal:  J Biol Chem       Date:  2004-10-13       Impact factor: 5.157

6.  Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas.

Authors:  C Cordon-Cardo; E Latres; M Drobnjak; M R Oliva; D Pollack; J M Woodruff; V Marechal; J Chen; M F Brennan; A J Levine
Journal:  Cancer Res       Date:  1994-02-01       Impact factor: 12.701

7.  Loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastoma.

Authors:  M V Kato; T Shimizu; K Ishizaki; A Kaneko; D W Yandell; J Toguchida; M S Sasaki
Journal:  Cancer Lett       Date:  1996-08-23       Impact factor: 8.679

Review 8.  RB1 in cancer: different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis.

Authors:  Riccardo Di Fiore; Antonella D'Anneo; Giovanni Tesoriere; Renza Vento
Journal:  J Cell Physiol       Date:  2013-08       Impact factor: 6.384

9.  Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.

Authors:  Aaron Aslanian; Phillip J Iaquinta; Raluca Verona; Jacqueline A Lees
Journal:  Genes Dev       Date:  2004-06-02       Impact factor: 11.361

Review 10.  MDM2, MDMX and p53 in oncogenesis and cancer therapy.

Authors:  Mark Wade; Yao-Cheng Li; Geoffrey M Wahl
Journal:  Nat Rev Cancer       Date:  2013-01-10       Impact factor: 60.716

  10 in total
  5 in total

Review 1.  Dual function of MDM2 and MDMX toward the tumor suppressors p53 and RB.

Authors:  Jesús Hernández-Monge; Adriana Berenice Rousset-Roman; Ixaura Medina-Medina; Vanesa Olivares-Illana
Journal:  Genes Cancer       Date:  2016-09

Review 2.  Roles of pRB in the Regulation of Nucleosome and Chromatin Structures.

Authors:  Chiharu Uchida
Journal:  Biomed Res Int       Date:  2016-12-22       Impact factor: 3.411

Review 3.  Role of Sex in the Therapeutic Targeting of p53 Circuitry.

Authors:  Francesca Mancini; Ludovica Giorgini; Emanuela Teveroni; Alfredo Pontecorvi; Fabiola Moretti
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

Review 4.  The long and the short of it: the MDM4 tail so far.

Authors:  Sue Haupt; Javier Octavio Mejía-Hernández; Reshma Vijayakumaran; Simon P Keam; Ygal Haupt
Journal:  J Mol Cell Biol       Date:  2019-03-01       Impact factor: 6.216

5.  miR‑205 suppresses cell migration, invasion and EMT of colon cancer by targeting mouse double minute 4.

Authors:  Yujing Fan; Kuanyu Wang
Journal:  Mol Med Rep       Date:  2020-05-18       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.